M C Garnett

Defining the drug incorporation properties of PLA-PEG nanoparticles.

T. Ehtezazi, S. Davis, S. Stolnik, 2000, International journal of pharmaceutics.

Preparation and in vitro characterization of HSA-mPEG nanoparticles.

E. Schacht, S. Davis, M. Garnett, 1999, International journal of pharmaceutics.

Preparation of surface-modified albumin nanospheres.

M C Garnett, L Illum, S S Davis, 1997, Biomaterials.

Nanomedicines and nanotoxicology: some physiological principles.

M. Garnett, P. Kallinteri, M C Garnett, 2006, Occupational medicine.

Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.

M C Davies, M. Davies, E. Schacht, 1997, Biomaterials.

PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.

S. Davis, S. Stolnik, M. Garnett, 1999, Journal of controlled release : official journal of the Controlled Release Society.

Preparation and characterisation of rose Bengal-loaded surface-modified albumin nanoparticles.

E. Schacht, S. Davis, P. Ferruti, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Poly(organo phosphazene) nanoparticles surface modified with poly(ethylene oxide).

M C Davies, E Schacht, M C Garnett, 1996, Biotechnology and bioengineering.

Gene-delivery systems using cationic polymers.

M. Garnett, M C Garnett, 1999, Critical reviews in therapeutic drug carrier systems.

In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres.

E. Schacht, S. Davis, E. Kenawy, 1998, Journal of pharmaceutical sciences.